No Association Between DAA Treatment for HCV Infection and Herpes Zoster Infection in Analysis of Data From 37 Clinical Trials

Recent case series and retrospective studies have raised concerns that patients who receive direct-acting antiviral treatment for hepatitis C virus (HCV) infection are at increased risk of developing varicella-zoster virus infection (VZV reactivation). We investigated the relationship between DAA treatment and VZV reactivation by analyzing pooled participant-level data from 37 clinical trials of DAA agents.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: research